NCT04885764 (ASU-VAC) is a Phase 2, PHASE3 clinical trial of Astrazeneca/Oxford Vaccine in Covid19, sponsored by Ain Shams University.

Who is sponsoring NCT04885764?

NCT04885764 is sponsored by Ain Shams University.

What drugs are being tested in NCT04885764?

Interventions in NCT04885764: Astrazeneca/Oxford Vaccine, Sinopharm vaccine.

Is NCT04885764 still recruiting?

NCT04885764 is currently status unknown. Last updated 13 May 2021.

Last reviewed 2021-05-13 · How we verify

NCT04885764: ASU-VAC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University

Status unknown Phase 2, PHASE3 Last updated 13 May 2021

What this trial tests

Phase 2, PHASE3 trial testing Astrazeneca/Oxford Vaccine in Covid19 in 4,000 participants. Status unknown.

Timeline

23 February 2021

Primary endpoint
1 October 2021

1 December 2021

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 2, PHASE3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	4,000
Start date	23 February 2021
Primary completion	1 October 2021
Estimated completion	1 December 2021
Sites	1 location across Egypt

Drugs / interventions tested

Astrazeneca/Oxford Vaccine — full drug profile →
Sinopharm vaccine — full drug profile →

Conditions studied

Covid19 — all drugs for Covid19 →

Sponsor

Ain Shams University

Who can join

18 and older, any sex, with Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective intervention study to assess the effectiveness of both the live attenuated and messenger RNA vaccines against SARS-CoV-2 infection

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

COVID-19 vaccine development: milestones, lessons and prospects.
Li M, Wang H, Tian L, Pang Z, et al · · 2022 · cited 298× · PMID 35504917 · DOI 10.1038/s41392-022-00996-y
Nanoparticles in clinical trials of COVID-19: An update.
Rauf A, Abu-Izneid T, Khalil AA, Hafeez N, et al · · 2022 · cited 22× · PMID 35953020 · DOI 10.1016/j.ijsu.2022.106818
COVID-19, the firestone in 21st century: a review on coronavirus disease and its clinical perspectives.
Karthika C, Swathy Krishna R, Rahman MH, Akter R, et al · · 2021 · cited 11× · PMID 34599450 · DOI 10.1007/s11356-021-16654-9
Antiviral fungal metabolites and some insights into their contribution to the current COVID-19 pandemic.
Takahashi JA, Barbosa BVR, Lima MTNS, Cardoso PG, et al · · 2021 · cited 9× · PMID 34438338 · DOI 10.1016/j.bmc.2021.116366
Appraisal of SARS-CoV-2 mutations and their impact on vaccination efficacy: an overview.
Hadizadeh N, Naderi M, Khezri J, Yazdani M, et al · · 2022 · cited 5× · PMID 35891981 · DOI 10.1007/s40200-022-01002-6

Verify or expand the search:

Other recruiting trials for Covid19

Currently open trials in the same condition.

NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04885764 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 13 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04885764.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing